Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on February 28, 2017. The report discloses the issuance of a press release and an updated investor presentation regarding the Company's financial performance for the quarter and full year ended December 31, 2016.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are not included in the provided text.
Material Changes
The filing does not detail specific material changes versus prior periods. It serves as a notification that financial results for the period ended December 31, 2016, have been announced via a press release.
Guidance, Outlook, and Risks
The Company posted an updated investor presentation to its website, which may be used in conversations with analysts and investors. The filing explicitly states that the information in the press release and investor presentation is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated. The Company undertakes no obligation to publicly update or revise the information in the investor presentation.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 28, 2017) for specific financial results for the quarter and year ended December 31, 2016.
- Examine Exhibit 99.2 (Investor Presentation) for management's outlook and strategic updates.
- Verify the Company's current name and status, noting the discrepancy between the metadata (Clearpoint Neuro, Inc.) and the filing registrant (MRI Interventions, Inc.).
- Confirm that the financial data in the exhibits is not automatically incorporated by reference into other SEC filings.